Latest Breaking News On - University of georgia chagas - Page 1 : vimarsana.com

License enables advancement of AN2-502998 (formerly known as AN15368), a boron-based small molecule therapeutic under development for the treatment of Chagas disease IND-enabling preclinical studies well underway in

United statesEric easomRick tarletonTherapeutics incDepartment of cellular biologyAnacor pharmaceuticals incUniversity of georgia research foundationUniversity of georgiaUniversity of georgia chagasWorld health organizationGeorgia chagasGeorgia research foundationAnacor pharmaceuticalsProfessor rick tarletonChief executive officerRegents professor